跳至主要内容
临床试验/NCT03933358
NCT03933358Unknown不适用

Effect of Thyroid Hormone on Post-Myocardial Infarction Remodeling and Prognosis in STEMI Patients

Beijing Friendship Hospital1 个研究点 分布在 1 个国家目标入组 250 人开始时间: 2019年5月1日最近更新:
适应症

试验速览

阶段
不适用
入组人数
250
试验地点
1
主要终点
MACE (major adverse cardiovascular events)

研究概览

简要总结

This study aims to determine whether thyroid hormone levels are predictive of cardiac remodeling following myocardial infarction and the prognosis in patients with STEMI receiving primary percutaneous coronary intervention.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • with a confirmed STEMI diagnosis
  • undergoing primary percutaneous coronary intervention (presenting <12h after symptom onset)
  • patients agreed and provided informed consent

排除标准

  • past history of myocardial infarction or percutaneous coronary intervention or coronary artery bypass graft
  • past history of heart failure (LVEF<40%) or myocardiopathy or atrial fibrillation
  • past history of thyroid diseases, or were treated with amiodarone, dopamine, or corticosteroids before hospital admission
  • contraindicating to cardiac magnetic resonance imaging

结局指标

主要结局

MACE (major adverse cardiovascular events)

时间窗: 12 months

cardiovascular death, re-infarction, revascularization, and stroke

次要结局

  • all-cause death(12 months)
  • adverse cardiac remodeling(6 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Hongwei Li, MD

Prof.

Beijing Friendship Hospital

研究点 (1)

Loading locations...

相似试验